r-studio version 0.98.1091 (RStudio)
90
Structured Review
RStudio
r-studio version 0.98.1091
R Studio Version 0.98.1091, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r-studio+version+0%2E98%2E1091/rstudio+version+0+98+1091/pm34538637-25-5-5
Average 90 stars, based on 1 article reviews
R Studio Version 0.98.1091, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r-studio+version+0%2E98%2E1091/rstudio+version+0+98+1091/pm34538637-25-5-5
Average 90 stars, based on 1 article reviews
r-studio version 0.98.1091 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy Article Snippet: Random allocation of age-matched women was performed with Article Title: Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery Article Snippet: Statistical analysis was performed using Article Title: The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position? Article Snippet: OC incidence per 1000 women-years at risk and the respective 95% Article Title: Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries. Article Snippet: Accepted Manuscript Title: Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries Authors: Natalia Teixeira, Simone Maistro, Maria Del Pilar Estevez Diz, Marian J. Mourits, Jan C. Oosterwijk, Maria Aparecida Koike Folgueira, Geertruida H. de Bock PII: S0378-5122(17)30590-X DOI: http://dx.doi.org/doi:10.1016/j.maturitas.2017.06.002 Reference: MAT 6836 To appear in: Maturitas Received date: 10-5-2017 Revised date: 22-5-2017 Accepted date: 1-6-2017 Please cite this article as: Teixeira Natalia, Maistro Simone, Del Pilar Estevez Diz Maria, Mourits Marian J, Oosterwijk Jan C, Folgueira Maria Aparecida Koike, de Bock Geertruida H.Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries.Maturitas http://dx.doi.org/10.1016/j.maturitas.2017.06.002 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Article Title: Weekly hypofractionated radiotherapy in older adult patients with cutaneous squamous cell carcinoma. Article Snippet: With the ageing population, the incidence rate of cutaneous squamous cell carcinoma (cSCC) increases steeply in older adult population [1].. This evidence poses important management challenges, due to older adult patients' clinical complexity, including comorbidities, cognitive impairment, and social issues.. In this context, definitive radiotherapy (RT) represents a powerful single option in the local treatment of cSCC, although its optimal scheme remains controversial. |